Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.

Abstract

<b>Rationale:</b> Chronic lung allograft dysfunction (CLAD) results in significant morbidity after lung transplantation. Potential CLAD occurs when lung function declines to 80-90% of baseline. Better noninvasive tools to prognosticate at potential CLAD are needed. <b>Objectives:</b> To determine whether parametric response mapping (PRM), a computed tomography (CT) voxel-wise methodology applied to high-resolution CT scans, can identify patients at risk of progression to CLAD or death. <b>Methods:</b> Radiographic features and PRM-based CT metrics quantifying functional small airway disease (PRM^fSAD) and parenchymal disease (PRM^PD) were studied at potential CLAD (<i>n</i> = 61). High PRM^fSAD and high PRM^PD were defined as ⩾30%. Restricted mean modeling was performed to compare CLAD-free survival among groups. <b>Measurements and Main Results:</b> PRM metrics identified the following three unique signatures: high PRM^fSAD (11.5%), high PRM^PD (41%), and neither (PRM^Normal; 47.5%). Patients with high PRM^fSAD or PRM^PD had shorter CLAD-free median survival times (0.46 yr and 0.50 yr) compared with patients with predominantly PRM^Normal (2.03 yr; <i>P</i> = 0.004 and <i>P</i> = 0.007 compared with PRM^fSAD and PRM^PD groups, respectively). In multivariate modeling adjusting for single- versus double-lung transplant, age at transplant, body mass index at potential CLAD, and time from transplant to CT scan, PRM^fSAD ⩾30% or PRM^PD ⩾30% continue to be statistically significant predictors of shorter CLAD-free survival. Air trapping by radiologist interpretation was common (66%), was similar across PRM groups, and was not predictive of CLAD-free survival. Ground-glass opacities by radiologist read occurred in 16% of cases and were associated with decreased CLAD-free survival (<i>P</i> < 0.001). <b>Conclusions:</b> PRM analysis offers valuable prognostic information at potential CLAD, identifying patients most at risk of developing CLAD or death.